Enhanced oral bioavailability of valsartan in rats using a supersaturable self-microemulsifying drug delivery system with P-glycoprotein inhibitors

References

• Apollo Scientific Limited. Safety data sheet. 2012. Denton (Manchester): Apollo Scientific Ltd. [accessed 2019 Jul 22]. http://www.apolloscientific.co.uk/downloads/msds/BIT0501_msds.pdf
   Google Scholar
• Baek IH, Kim JS, Ha ES, Choo GH, Cho W, Hwang SJ, Kim MS. 2014. Oral absorption of a valsartan-loaded spray-dried emulsion based on hydroxypropylmethyl cellulose. Int J Biol Macromol. 69:222–228.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S, Beg S, Katare OP, Sharma G, Singh B. 2015. QbD-oriented development of self-nanoemulsifying drug delivery systems (SNEDDS) of valsartan with improved biopharmaceutical performance. CDD. 12(5):544–563.
   PubMed Web of Science ®Google Scholar
• Berggren S, Hoogstraate J, Fagerholm U, Lennernäs H. 2004. Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models. Eur J Pharm Sci. 21(4):553–560.
   PubMed Web of Science ®Google Scholar
• Borhade V, Nair H, Hegde D. 2008. Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS PharmSciTech. 9(1):13–21.
   PubMed Web of Science ®Google Scholar
• Challa VR, Ravindra Babu P, Challa SR, Johnson B, Maheswari C. 2013. Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models. Drug Dev Ind Pharm. 39(6):865–872.
   PubMed Web of Science ®Google Scholar
• Ćirin DM, Poša MM, Krstonošić VS, Milanović ML. 2012. Conductometric study of sodium dodecyl sulfate-nonionic surfactant (Triton X-100, Tween 20, Tween 60, Tween 80 or Tween 85) mixed micelles in aqueous solution. Hem Ind. 66(1):21–28.
   Web of Science ®Google Scholar
• Constantinides PP, Wasan KM. 2007. Lipid formulation strategies for enhancing intestinal transport and absorption of P‐glycoprotein (P‐gp) substrate drugs: In vitro/in vivo case studies. J Pharm Sci. 96(2):235–248.
   PubMed Web of Science ®Google Scholar
• Constantinides PP. 1995. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 12(11):1561–1572.
   PubMed Web of Science ®Google Scholar
• Cornaire G, Woodley J, Hermann P, Cloarec A, Arellano C, Houin G. 2004. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm. 278(1):119–131.
   PubMedGoogle Scholar
• Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. 2009. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release. 133(1):11–17.
   PubMed Web of Science ®Google Scholar
• Dewanjee S, Dua T, Bhattacharjee N, Das A, Gangopadhyay M, Khanra R, Joardar S, Riaz M, Feo VD, Zia-Ul-Haq M. 2017. Natural products as alternative choices for P-glycoprotein (P-gp) inhibition. Molecules. 22(6):871.
   PubMed Web of Science ®Google Scholar
• Dezani TM, Dezani AB, da Silva Junior JB, dos Reis Serra CH. 2016. Single-Pass Intestinal Perfusion (SPIP) and prediction of fraction absorbed and permeability in humans: a study with antiretroviral drugs. Eur J Pharm Biopharm. 104:131–139.
   PubMed Web of Science ®Google Scholar
• Dixit AR, Rajput SJ, Patel SG. 2010. Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS PharmSciTech. 11(1):314–321.
   PubMed Web of Science ®Google Scholar
• Ferté J. 2000. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane. Eur J Biochem. 267(2):277–294.
   PubMedGoogle Scholar
• Flesch G, Müller P, Lloyd P. 1997. Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man. Eur J Clin Pharmacol. 52(2):115–120.
   PubMed Web of Science ®Google Scholar
• Ginanneschi F, Volpi N, Giannini F, Rocchi R, Donati D, Aglianò M, Lorenzoni P, Rossi A. 2014. Rhabdomyolysis in an elderly multitreated patient: multiple drug interactions after statin withdrawal. J Neurol Sci. 336(1–2):284–287.
   PubMed Web of Science ®Google Scholar
• Greiner B, Eichelbaum M, Fritz P, Kreichgauer HP, von Richter O, Zundler J, Kroemer HK. 1999. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest. 104(2):147–153.
   PubMed Web of Science ®Google Scholar
• Hedayati S, Bernareggi A, Rowland M. 1992. Absorption kinetics of cyclosporin in the rat. J Pharm Pharmacol. 44(2):122–124.
   PubMed Web of Science ®Google Scholar
• Kang MJ, Kim HS, Jeon HS, Park JH, Lee BS, Ahn BK, Moon KY, Choi YW. 2012. In situ intestinal permeability and in vivo absorption characteristics of olmesartan medoxomil in self-microemulsifying drug delivery system. Drug Dev Ind Pharm. 38(5):587–596.
   PubMed Web of Science ®Google Scholar
• Kim MS, Baek IH. 2014. Fabrication and evaluation of valsartan-polymer-surfactant composite nanoparticles by using the supercritical antisolvent process. Int J Nanomedicine. 9(1):5167–5176.
   PubMedGoogle Scholar
• Lee DH, Yeom DW, Song YS, Cho HR, Choi YS, Kang MJ, Choi YW. 2015. Improved oral absorption of dutasteride via Soluplus®-based supersaturable self-emulsifying drug delivery system (S-SEDDS). Int J Pharm. 478(1):341–347.
   PubMed Web of Science ®Google Scholar
• Lee JY, Kang WS, Piao J, Yoon IS, Kim DD, Cho HJ. 2015. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan. Drug Des Devel Ther. 9:2745–2756.
   PubMed Web of Science ®Google Scholar
• Lee SK, Jeon SG, Kang JS, Lee JH, Choi YW. 2007. SMEDDS (Seif-Micro Emulsifying Drug Delivery System) as an intraurethral prostaglandin E1 delivery system. J Kor Pharm Sci. 37(5):291–295.
   Google Scholar
• Li M, Si L, Pan H, Rabba AK, Yan F, Qiu J, Li G. 2011. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion. Int J Pharm. 403(1–2):37–45.
   PubMed Web of Science ®Google Scholar
• Lin Y, Shen Q, Katsumi H, Okada N, Fujita T, Jiang X, Yamamoto A. 2007. Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats. Biol Pharm Bull. 30(7):1301–1307.
   PubMed Web of Science ®Google Scholar
• Lo YL. 2003. Relationships between the hydrophilic–lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. J Control Release. 90(1):37–48.
   PubMed Web of Science ®Google Scholar
• Luo Z, Liu Y, Zhao B, Tang M, Dong H, Zhang L, Lv B, Wei L. 2013. Ex vivo and in situ approaches used to study intestinal absorption. J Pharmacol Toxicol Methods. 68(2):208–216.
   PubMed Web of Science ®Google Scholar
• Malcolmson C, Satra C, Kantaria S, Sidhu A, Lawrence MJ. 1998. Effect of oil on the level of solubilization of testosterone propionate into nonionic oil‐in‐water microemulsions. J Pharm Sci. 87(1):109–116.
   PubMed Web of Science ®Google Scholar
• Negi LM, Tariq M, Talegaonkar S. 2013. Nano scale self-emulsifying oil based carrier system for improved oral bioavailability of camptothecin derivative by P-Glycoprotein modulation. Colloids Surf B Biointerfaces. 111:346–353.
   PubMed Web of Science ®Google Scholar
• Nekkanti V, Wang Z, Betageri GV. 2016. Pharmacokinetic evaluation of improved oral bioavailability of valsartan: proliposomes versus self-nanoemulsifying drug delivery system. AAPS PharmSciTech. 17(4):851–862.
   PubMed Web of Science ®Google Scholar
• Park HS, Han JH, Jung SH, Jo EJ, Myung CS. 2016. The combination of valsartan and ramipril protects against blood vessel injury and lowers blood pressure. J Pharm Investig. 46(3):265–272.
   Google Scholar
• Rege BD, Kao JP, Polli JE. 2002. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci. 16(4–5):237–246.
   PubMed Web of Science ®Google Scholar
• Regev R, Assaraf YG, Eytan GD. 1999. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P‐glycoprotein ATPase activity and modulates efflux from multidrug‐resistant cells. Eur J Biochem. 259(1–2):18–24.
   PubMedGoogle Scholar
• Sangsen Y, Wiwattanawongsa K, Likhitwitayawuid K, Sritularak B, Graidist P, Wiwattanapatapee R. 2016. Influence of surfactants in self-microemulsifying formulations on enhancing oral bioavailability of oxyresveratrol: studies in Caco-2 cells and in vivo. Int J Pharm. 498(1–2):294–303.
   PubMedGoogle Scholar
• Schmidt EK, Antonin KH, Flesch G, Racine-Poon A. 1998. An interaction study with cimetidine and the new angiotensin II antagonist valsartan. Eur J Clin Pharmacol. 53(6):451–458.
   PubMed Web of Science ®Google Scholar
• Shono Y, Nishihara H, Matsuda Y, Furukawa S, Okada N, Fujita T, Yamamoto A. 2004. Modulation of intestinal P‐glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes. J Pharm Sci. 93(4):877–885.
   PubMed Web of Science ®Google Scholar
• Siddiqui N, Husain A, Chaudhry L, Alam MS, Mitra M, Bhasin PS. 2011. Pharmacological and pharmaceutical profile of valsartan: a review. J Appl Pharm Sci. 1(04):12–19.
   Google Scholar
• Sigma-Aldrich. 2014. Material Safety Data Sheet. Saint Louis (MO): Sigma-Aldrich; [accessed 2019 Oct 15]. https://www.nwmissouri.edu/naturalsciences/sds/t/Tween%2020.pdf
   Google Scholar
• Singh AK, Chaurasiya A, Awasthi A, Mishra G, Asati D, Khar RK, Mukherjee R. 2009. Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS). AAPS PharmSciTech. 10(3):906–916.
   PubMed Web of Science ®Google Scholar
• Sinicrope FA, Dudeja PK, Bissonnette BM, Safa AR, Brasitus TA. 1992. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles. J Biol Chem. 267(35):24995–25002.
   PubMed Web of Science ®Google Scholar
• Song IS, Cha JS, Choi MK. 2015. Enhanced oral bioavailability of naringenin administered in a mixed micelle formulation with Pluronic F127 and Tween 80 in rats. J Pharm Investig. 45(7):633–640.
   Google Scholar
• Spectrum. 2008. Material Safety Data Sheet Gardena (CA): Spectrum Laboratory Product Inc; [accessed 2019 Jul 22]. https://www.spectrumchemical.com/MSDS/YY998.pdf
   Google Scholar
• Sutton SC, Rinaldi MTS, Vukovinsky KE. 2001. Comparison of the gravimetric, phenol red, and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model. AAPS PharmSci. 3(3):93.
   Google Scholar
• Takano R, Kataoka M, Yamashita S. 2012. Integrating drug permeability with dissolution profile to develop IVIVC. Biopharm Drug Dispos. 33(7):354–365.
   PubMed Web of Science ®Google Scholar
• Terao T, Hisanaga E, Sai Y, Tamai I, Tsuji A. 1996. Active secretion of drugs from the small intestinal epithelium in rats by P‐glycoprotein functioning as an absorption barrier. J Pharm Pharmacol. 48(10):1083–1089.
   PubMed Web of Science ®Google Scholar
• Ujhelyi Z, Fenyvesi F, Váradi J, Fehér P, Kiss T, Veszelka S, Deli M, Vecsernyés M, Bácskay I. 2012. Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer. Eur J Pharm Sci. 47(3):564–573.
   PubMed Web of Science ®Google Scholar
• Varma MV, Ashokraj Y, Dey CS, Panchagnula R. 2003. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res. 48(4):347–359.
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun J, Zhang T, Liu H, He F, He Z. 2011. Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems. Drug Dev Ind Pharm. 37(10):1225–1230.
   PubMed Web of Science ®Google Scholar
• Warisnoicharoen W, Lansley AB, Lawrence MJ. 2000. Nonionic oil-in-water microemulsions: the effect of oil type on phase behaviour. Int J Pharm. 198(1):7–27.
   PubMed Web of Science ®Google Scholar
• Yan YD, Sung JH, Kim KK, Kim DW, Kim JO, Lee BJ, Yong CS, Choi HG. 2012. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Int J Pharm. 422(1–2):202–210.
   PubMedGoogle Scholar
• Yeom DW, Chae BR, Son HY, Kim JH, Chae JS, Song SH, Oh D, Choi YW. 2017. Enhanced oral bioavailability of valsartan using a polymer-based supersaturable self-microemulsifying drug delivery system. IJN. 12:3533–3545.
   Google Scholar
• Yeom DW, Song YS, Kim SR, Lee SG, Kang MH, Lee S, Choi YW. 2015. Development and optimization of a self-microemulsifying drug delivery system for atorvastatin calcium by using D-optimal mixture design. Int J Nanomedicine. 10:3865–3875.
   PubMed Web of Science ®Google Scholar
• Yin YM, Cui FD, Mu CF, Choi MK, Kim JS, Chung SJ, Shim CK, Kim DD. 2009. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Control Release. 140(2):86–94.
   PubMed Web of Science ®Google Scholar
• Zakeri-Milani P, Valizadeh H, Tajerzadeh H, Azarmi Y, Islambolchilar Z, Barzegar S, Barzegar-Jalali M. 2007. Predicting human intestinal permeability using single-pass intestinal perfusion in rat. J Pharm Pharm Sci. 10(3):368–379.
   PubMed Web of Science ®Google Scholar
• Zhao, G, Huang, J, Xue, K, Si, L, Li, G. 2013. Enhanced intestinal absorption of etoposide by self-microemulsifying drug delivery systems: roles of P-glycoprotein and cytochrome P450 3A inhibition.  Eur J Pharm Sci. 50(3–4):429–439.
   Google Scholar
• Zhu Y, Zhang J, Zheng Q, Wang M, Deng W, Li Q, Firempong CK, Wang S, Tong S, Xu X, Yu J. 2015. In vitro and in vivo evaluation of capsaicin‐loaded microemulsion for enhanced oral bioavailability. J Sci Food Agric. 95(13):2678–2685.
   PubMed Web of Science ®Google Scholar